Member Info for thomasbrowne

I don't know when the patent will be granted that's why I put in the (possibly ) It can take as little as 3 months or up to 9 years, As MED is already patented and we are just looking for a new increase of the med formulation I would expect this new patent to be quicker , but in saying that there's no guarantee that it will be quicker. But the good thing about MED is that we already have it covered by our existing patent and Fums patent lawyer's are confident about the latest submission with a new MED higher formulation extension giving us a very lucrative New 2038 guaranteed income stream. So it's not to important if the patent is not granted in March. We have protection for another 7 years anyway. And I'm sure it will be granted ASP. GLA great start to the new year .

It shouldn't be to long before fum gets well over 50p Mark giving me a 100% profit and I'm genuinely not even tempted to sell, 90p will have me thinking twice but this share will only be starting to light up and there's a bigger end game to fums independence than any of my guesstimates. Fums New patent for MED submitted in March last year to extend med to 2038 should be confirmed around March of this year , and increasing massively the lucrative income stream and guaranteeing that income stream for fum or its new owners with a strongly tipped takover. So a extension of MED patent to 2038 possible confirmation around late March ??? Results from PK study around late March. Confirmation of significant worldwide MED contracts in late March Confirmation of contracts of the pain portfolio before late March Clarity and confirmation of csd Condon contracts before late March. I'm expecting a worldwide med contract to be signed with GSK before late March . GSK A COMPANY VALUED AT �65.500 billion , I would gladly accept a several hundred million POUND paper takover from GSK. And could that offer possibly come in late March ???

A cheeky offer for fum would start at a low �2. And wouldn't succeed in my opinion? The numbers involved Regarding profits would be just to high to accept a �2 offer , it wouldn't be a offer it would be theft. GLA

A ready and waiting in-built prescription market delivering tens of millions of a guaranteed income stream For fums shareholders . Does anyone really believe fums valuation won't massively jump many times it's current price. There is no better opportunity to make money than right here right now, I'm now sitting on �6000 profit and I'm not even tempted in the slightest to take that profit. There's many times that profit to come from fum. The funs only starting here, a few days into the new year and gums delivering as expected. GLA

Could FUM be the next ASOS ? Never say never, stranger things happen. Go on we fum , just get all them contracts signed and release them to the market and fums share price will hit historical highs 90p+ to start with I'm100% confident fum will sign substantial financially rewarding contracts.in the next few months. Exciting to be aboard with fum in 2018

I absolutely agree with coldascheese, fum lost market confidence when church & Dwight relinquished the csd500 contract and the rights. That kind of knock back would hurt a small minnow like fum. There's plenty of money to be made from the bluediamond condom skimming a good amount of money from every country around the world, especially china? I'm genuinely expecting fum to hit +55p in the next few months and I wouldn't be in the least surprised if Fum hit 60p to 90p + There's no comparing the blue diamond condom with the massive potential of med202 Med202 has a guaranteed UN- met market to take as there's nothing for ED sufferes with cardiovascular problems to take from prescriptions 10%14% UN-met market. This translates into a guaranteed multi million pound revenue stream and then there's the over the counter market.and that would also surly be extremely valuable to fum and us it's shareholders. I'm expecting a massive 're- rating for fums share price. I genuinely can't see any other company with its potential and it won't belong before market confidence and reconnection propel fum to even a reasonable reflection of its true worth. ITS going to be a fantastic year for FUM ALL IMHO

Fum has the potential for a 60p 90p medium term rise IMHO .it will just take clarity on its med202 contracts And with the accompanying spotlight being put on its potential and huge pay outs from the contracts.the share price will easily retrace its highs of the last several months.the world wide potential is massive and the prescription market for patients with erectile dysfunction who can't take any current medications is also huge and a unmet market.so at the very least that 7% unmet world wide market is worth many millions of profit for fum and the big companies that will sign contracts with fum. Everything looks perfect for a substantial 're -rating of fum GLA 2018 it will be a fantastic new year.

Thelagerkhan that's such a pity owning 25000 Asos shares and selling them , but at that time you done the right thing and bagged a good profit , because I have seen loads of clothing companies fold with one bad year off losses , and I always new they were very risky long term, but to think you could be worth £1.7 M if you had held on to them makes me shudder with a OMG moment. Still fum just might surprise us all , none of us are mystic meggs and we all have made good and had choices? I have seen that many companies tread water for months and years like fum and then take off never to see a low share price ever again, I remember acorn from which ARM was spun out from and I couldn't get that saying out of my head , from small acorns big things grow,?!!! and read about how good the arm division was but still wanted the quick profit and didn't invest at all ,and that saying I never forgot!!! , and it was snapped up for £24 BILLION LOL So its true a few thousand pounds here and there in companies that are recommended with potential should pay off long term.?! My only reservation now is a market correction is well overdue in America and = the rest of the world and that could hit sentiment.. but if fum have indeed hit the jackpot with med202 and all along its CEO has thought that it was possibly the most valuable asset they had , then any market correction will make very little difference to fums future shy high valuation. The CEO James barder is a decent bloke and is trying his best to get shareholder value . Though it doesn't always look like that sometimes.LOL Ionic I completely share your reluctance to tie money up long term or even invest for long terms in good solid companies with good dividends like Warren buffets stragedy!!! But what does he know LOL LOL. I'M STICKING WITH FUM LONG TERM . Or at least for 2/3 years from now onwards,.and see were that goes .it's definitely worth the risk in my opinion. Merry Xmas everyone

It always just seems like everything takes absolutely forever????? I do agree with that view , but it reminds me of a really great double page spread in investors chronicle in 2000 /3 or /4 A article about why you should buy the shares In ASOS GROUP and look to the future when more people buy cloths online, and the share price was 14pence in 2004 and I couldn't wait for years , and now they are £67.75pence . So really a few pounds spread around different shares seems the safest option. Futura medical have the same potential ,but that's just in my view . So is a few years a long time to wait I doubt very much anyone will have to wait 2 years to make a substantial profit on futuras current share price. imho good luck and have a fantastic Xmas

Fum won't fall by the wayside, it's sitting on the world's first clinically proven fastest acting penile erectile spray , and there's a inbuilt prescription market already there, throw in the over the counter market and there's a substantial bussiness proportion just sitting there at 23p a share and a market value of £29M . If med202 is successful then we can be assured of a substantial offer from one of the major players, and then and only then can the name futura medical fall by the wayside. GLA

£3800

It's hard to believe I made £ 3800 from akers early in the year, such a risky company to invest in. I should have made double that only I didn't press sell when I had the MM offer in front of me. I wouldn't trust Ray aker with a penny of my money . And I suspect I was just a lucky investor that got out at the right time. Please if there's any new investors thinking about investing here in akers be prepared to loose most of your money as akers has swallowed up 100 million dollars so far ,and it doesn't care how many times the shares are diluted down to nothing , that's why the directors shun buying there own shares.. There should be a serious warning on buying these shares, I'm a rare lucky one who got out before the again and again collapse. Buyer beware .

The 3rd trial result is not factored into the SP ,»»»that's my point «««, that's why the shares are at a ridiculous low valuation?. Futura medical will sign it's med202 contracts with minor and major companies before the 3rd trial is even started ««««.and it's only the extremely useful PK study to determine med202 dosage that is holding back the contracts being signed, and when they are signed then I would expect a share price a lot higher than 23p . To my knowledge it's normally around the 3rd trial results before or after That result do other big pharmaceutical companies run there rulers over futuras independence. Remember there's also a update on the pain meds contracts in January. So there's loads of strong possibilities for substantial SP rerating. GLA .

Please read the results of the 2nd trial from futura medical. As I stated the results were so strong in every direction that the 3 rd trial is mainly just a confirmation of the 2 nd trial but with a added bonus of a stronger dose to see just what strength can be used to optimize the sprays greatest strengths to get the best prescription dosage . It's a done deal by just reading how good the 2 nd trial results were. Ps . If I'm a damper I didn't realize it. It's just my opinion .

Fum is a exceptional buy in my opinion, that last trade at 23.80 was my buy and not a sell as indicated on this site. There's going to be several very important announcements very early in the new year. each one of these announcements should independently increase futures share price substantially. The pain medications deals should be the first announcements, and I'm expecting med202 deals to be announced even before the end of the first quarter and the PK study results gets officially announced, the PK results would probably be shared with the big majors and speed up the formal exchanging of contracts, It's very clear that the 2nd med202 trial was so compelling a cross the board with all its data, that the big majors know that the 3rd trial is only to complete the formal process, the potential for med202 at its lowest expected sales is still enormous, and at its highest could potentially turn futura medical into a extremely valuable company. The sums involved are so high I'm reluctant to even guess futura ultimate valuation. But I have invested in 60000 shares and I'm happy to wait for a expected massive takeover offer. And I will be happy with another pharmaceutical share to hold from that massive takeover offer. Future medical is a definite and exceptional strong buy and hold. It will be interesting to see if any financial tipsters tip them for 2018 and beyond . FLA

Foldax is definitely not even worth $3 m I challenge anyone who proves differently If aortech cared anything about its private shareholders it would sell its IP and sell its listing to someone who actually has a credible bussiness plan , that's the best way to monetise any thing it owns. When aortech can't raise funds to try and develops its own bussiness plan it means there's very little faith in it . And investors don't want there money used like a roll of the dice. Aortech sell up please . I'm not a investor and never have been a investor in aortech thank goodness .

This is money was raised from 2013 to run foldax and developing the heart valve ,and most of this money has been spent, in 2017 foldax could only raise $300k ? Only ? ,I don't know how much money foldax has left in the bank but it's definitely not millions ? I'm happy to be corrected !!!? Im surgeryre frank mcguire gets a big remuneration package and eating into foldax funding from 2013 If foldax investors totally understand what Frank mcguires capable of they wouldn't fund his new company The only people he serves is himself and shouldn't be trusted, with anyone's investment money . What he done to aortech was a serious criminal act , and completely against his own service contract.. Aortech has a case against him personally and also against foldax . I'm hoping frank mcguire has money hidden somewhere , and in my opinion he destroyed aortech and shareholders trust and he should return a substantial amount of his remuneration package gained from aortech , he's what you would call a serious low life ,and he should never be given any roll of responsibility In running any bussiness venture. If he had any great amount of money then substantial criminal damages should be sought directly from him and foldax, if foldax had insurance then it might pay out, but I can't see any insurance company paying out under these circumstances. As foldax could possibly have been started under criminal circumstances? As will be bore out when a settlement is achieved..?!!! GLA

I have no idea were you get the $16 million from? I can't locate any large amounts of money owned by Frank or foldax , that's why I'm concerned about retrieving a reasonable amount of money!!! If frank or foldax had any decent amounts of money then the punitive amount of damages that could be sued for could have been really substantial, in the usa them type of damages can be enormous. And if they don't have any great amounts of money then just getting the IP back from foldax would be expected . Unless foldax gives aortech a large shareholding in foldax!? . My guess is , getting all the IP back and licencing aortechs ip back to foldax for a reasonable amount of money and possibly paying all aortech legal fees and some damages. ? Or paying aortech money over several years ? It shouldn't be longer before its settled !!!??? GLA

Guss3000 I really gained some great and very important pointers from your post , it just goes to show you how different investors benefit from each other's knowledge . And who knows what other problems hide in accrols. Skeleton cupboard , LOL

Thank you for that Gus3000. It looks. like these paper price rises could be here for some time , compared to the normal fluctuations of paper prices. , the strength of the euro against the pound and brixit complications could really hamper accrols business plan, thus the urgent need for life saving funds to withstand potential huge losses , And to keep the company afloat until long term paper prices become clearer, accrol have secured all these contracts. With supermarkets with very low profit margins, and if paper prices rise any further for any reason / brixit exchanges rates etc, then because of all accrols long term contracts it could be devastating to the company? Only a possible plea to the supermarkets for a rewriting of the contracts could save the day, ??? But the risk was in the prospectus about reel prices effecting its bussiness plan !!!.